Tissue Engineered Vascular Grafts

COMBINATION_PRODUCT2 trials

Conditions

Cardiovascular AbnormalitiesCardiovascular DiseasesDILV - Double Inlet Left VentricleDORVHLH - Hypoplastic Left Heart SyndromeHeart Defects, CongenitalHeart DiseasesMitral Atresia

Phase 1

A Pilot Study Investigating the Clinical Use of Tissue Engineered Vascular Grafts in Congenital Heart Surgery

CompletedNCT01034007

Christopher BreuerSingle Ventricle Cardiac Anomaly

Start: 2009-12-31End: 2018-01-23Updated: 2018-03-02

Phase 2

Two-Year Study of the Safety and Efficacy of the Second-Generation Tissue Engineered Vascular Grafts

RecruitingNCT04467671

Nationwide Children's HospitalCardiovascular Abnormalities, Cardiovascular Diseases, DILV - Double Inlet Left Ventricle +8

Start: 2020-07-15End: 2027-08-31Target: 24Updated: 2025-06-27

Tissue Engineered Vascular Grafts

Sponsors

Conditions

Phase 1

Phase 2